Mechanisms of brca1–bard1 nucleosome recognition and ubiquitylation

ABSTRACT The BRCA1–BARD1 tumour suppressor is an E3 ubiquitin ligase necessary for the repair of DNA double-strand breaks by homologous recombination1,2,3,4,5,6,7,8,9,10. The BRCA1–BARD1

complex localizes to damaged chromatin after DNA replication and catalyses the ubiquitylation of histone H2A and other cellular targets11,12,13,14. The molecular bases for the recruitment to

double-strand breaks and target recognition of BRCA1–BARD1 remain unknown. Here we use cryo-electron microscopy to show that the ankyrin repeat and tandem BRCT domains in BARD1 adopt a

compact fold and bind to nucleosomal histones, DNA and monoubiquitin attached to H2A amino-terminal K13 or K15, two signals known to be specific for double-strand breaks15,16. We further

show that RING domains17 in BRCA1–BARD1 orient an E2 ubiquitin-conjugating enzyme atop the nucleosome in a dynamic conformation, primed for ubiquitin transfer to the flexible

carboxy-terminal tails of H2A and variant H2AX. Our work reveals a regulatory crosstalk in which recognition of monoubiquitin by BRCA1–BARD1 at the N terminus of H2A blocks the formation of

polyubiquitin chains and cooperatively promotes ubiquitylation at the C terminus of H2A. These findings elucidate the mechanisms of BRCA1–BARD1 chromatin recruitment and ubiquitylation

specificity, highlight key functions of BARD1 in both processes and explain how BRCA1–BARD1 promotes homologous recombination by opposing the DNA repair protein 53BP1 in post-replicative

chromatin18,19,20,21,22. These data provide a structural framework to evaluate BARD1 variants and help to identify mutations that drive the development of cancer. Access through your

institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Access Nature and 54 other Nature Portfolio

journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 51 print issues and online access $199.00 per

year only $3.90 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during

checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS BARD1 READS H2A

LYSINE 15 UBIQUITINATION TO DIRECT HOMOLOGOUS RECOMBINATION Article 28 July 2021 STRUCTURE OF THE HUMAN BRE1 COMPLEX BOUND TO THE NUCLEOSOME Article Open access 22 March 2024 BRCA1/BARD1

SITE-SPECIFIC UBIQUITYLATION OF NUCLEOSOMAL H2A IS DIRECTED BY BARD1 Article 15 February 2021 DATA AVAILABILITY The atomic coordinates and EM maps have been deposited in the Protein Data

Bank under accession codes 7LYA (NCP), 7LYB (BRCA1R–BARD1R–UbcH5c–NCP) and 7LYC (BARD1(ARD–BRCT)–NCPH2AK13ubK15ub), and in the Electron Microscopy Data Bank under corresponding accession

codes EMD-23590, EMD-23591 and EMD-23592. Raw gels and blots are provided in Supplementary Figs. 1–6. Reagents from this study are available from the corresponding author on request. CHANGE

HISTORY * _ 17 AUGUST 2021 A Correction to this paper has been published: https://doi.org/10.1038/s41586-021-03881-w _ REFERENCES * Hall, J. M. et al. Linkage of early-onset familial breast

cancer to chromosome 17q21. _Science_ 250, 1684–1689 (1990). Article  CAS  PubMed  ADS  Google Scholar  * Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility

gene BRCA1. _Science_ 266, 66–71 (1994). Article  CAS  PubMed  ADS  Google Scholar  * Futreal, P. A. et al. BRCA1 mutations in primary breast and ovarian carcinomas. _Science_ 266, 120–122

(1994). Article  CAS  PubMed  ADS  Google Scholar  * Friedman, L. S. et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. _Nat.

Genet_. 8, 399–404 (1994). Article  CAS  PubMed  Google Scholar  * Wu, L. C. et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. _Nat. Genet_. 14,

430–440 (1996). Article  CAS  PubMed  Google Scholar  * Scully, R. et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. _Cell_ 88, 265–275 (1997). Article  CAS  PubMed 

Google Scholar  * Zhao, W. et al. BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing. _Nature_ 550, 360–365 (2017). Article  CAS  PubMed  PubMed Central  ADS  Google Scholar  *

Moynahan, M. E., Chiu, J. W., Koller, B. H. & Jasin, M. Brca1 controls homology-directed DNA repair. _Mol. Cell_ 4, 511–518 (1999). Article  CAS  PubMed  Google Scholar  * Paull, T. T.,

Cortez, D., Bowers, B., Elledge, S. J. & Gellert, M. Direct DNA binding by Brca1. _Proc. Natl Acad. Sci. USA_ 98, 6086–6091 (2001). Article  CAS  PubMed  PubMed Central  ADS  Google

Scholar  * Tarsounas, M. & Sung, P. The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication. _Nat. Rev. Mol. Cell Biol_. 21, 284–299 (2020). Article  CAS  PubMed  PubMed

Central  Google Scholar  * Nakamura, K. et al. H4K20me0 recognition by BRCA1–BARD1 directs homologous recombination to sister chromatids. _Nat. Cell Biol_. 21, 311–318 (2019). Article  CAS 

PubMed  PubMed Central  Google Scholar  * Saredi, G. et al. H4K20me0 marks post-replicative chromatin and recruits the TONSL–MMS22L DNA repair complex. _Nature_ 534, 714–718 (2016). Article

  CAS  PubMed  PubMed Central  ADS  Google Scholar  * Kalb, R., Mallery, D. L., Larkin, C., Huang, J. T. & Hiom, K. BRCA1 is a histone-H2A-specific ubiquitin ligase. _Cell Rep_. 8,

999–1005 (2014). Article  CAS  PubMed  PubMed Central  Google Scholar  * Densham, R. M. et al. Human BRCA1–BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection.

_Nat. Struct. Mol. Biol_. 23, 647–655 (2016). Article  CAS  PubMed  PubMed Central  Google Scholar  * Mattiroli, F. et al. RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage

signaling. _Cell_ 150, 1182–1195 (2012). Article  CAS  PubMed  Google Scholar  * Gatti, M. et al. A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by RNF168 ubiquitin

ligase. _Cell Cycle_ 11, 2538–2544 (2012). Article  CAS  PubMed  PubMed Central  Google Scholar  * Brzovic, P. S., Rajagopal, P., Hoyt, D. W., King, M. C. & Klevit, R. E. Structure of a

BRCA1–BARD1 heterodimeric RING–RING complex. _Nat. Struct. Biol_. 8, 833–837 (2001). Article  CAS  PubMed  Google Scholar  * Bunting, S. F. et al. 53BP1 inhibits homologous recombination in

_Brca1_-deficient cells by blocking resection of DNA breaks. _Cell_ 141, 243–254 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Bouwman, P. et al. 53BP1 loss rescues BRCA1

deficiency and is associated with triple-negative and BRCA-mutated breast cancers. _Nat. Struct. Mol. Biol_. 17, 688–695 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  *

Chapman, J. R., Sossick, A. J., Boulton, S. J. & Jackson, S. P. BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair. _J. Cell Sci_. 125,

3529–3534 (2012). CAS  PubMed  PubMed Central  Google Scholar  * Pellegrino, S., Michelena, J., Teloni, F., Imhof, R. & Altmeyer, M. Replication-coupled dilution of H4K20me2 guides 53BP1

to pre-replicative chromatin. _Cell Rep_. 19, 1819–1831 (2017). Article  CAS  PubMed  PubMed Central  Google Scholar  * Greenberg, R. A. Assembling a protective shield. _Nat. Cell Biol_.

20, 862–863 (2018). Article  CAS  PubMed  PubMed Central  Google Scholar  * Liang, Y. et al. Structural analysis of BRCA1 reveals modification hotspot. _Sci. Adv_. 3, e1701386 (2017).

Article  PubMed  PubMed Central  ADS  CAS  Google Scholar  * Hashizume, R. et al. The RING heterodimer BRCA1–BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. _J.

Biol. Chem_. 276, 14537–14540 (2001). Article  CAS  PubMed  Google Scholar  * Mallery, D. L., Vandenberg, C. J. & Hiom, K. Activation of the E3 ligase function of the BRCA1/BARD1 complex

by polyubiquitin chains. _EMBO J_. 21, 6755–6762 (2002). Article  CAS  PubMed  PubMed Central  Google Scholar  * Stewart, M. D. et al. BARD1 is necessary for ubiquitylation of nucleosomal

histone H2A and for transcriptional regulation of estrogen metabolism genes. _Proc. Natl Acad. Sci. USA_ 115, 1316–1321 (2018). Article  CAS  PubMed  PubMed Central  Google Scholar  *

Fradet-Turcotte, A. et al. 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark. _Nature_ 499, 50–54 (2013). Article  CAS  PubMed  PubMed Central  ADS  Google Scholar  *

Wilson, M. D. et al. The structural basis of modified nucleosome recognition by 53BP1. _Nature_ 536, 100–103 (2016). Article  CAS  ADS  PubMed  Google Scholar  * Botuyan, M. V. et al.

Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. _Cell_ 127, 1361–1373 (2006). Article  CAS  PubMed  PubMed Central  Google

Scholar  * Stewart, G. S. et al. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. _Cell_ 136, 420–434 (2009). Article  CAS  PubMed  Google

Scholar  * Doil, C. et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. _Cell_ 136, 435–446 (2009). Article  CAS  PubMed

  Google Scholar  * Becker, J. R. et al. BARD1 links histone H2A lysine-15 ubiquitination to initiation of BRCA1-dependent homologous recombination. Preprint at 

https://doi.org/10.1101/2020.06.01.127951 (2020). * Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F. & Richmond, T. J. Crystal structure of the nucleosome core particle at 2.8 A

resolution. _Nature_ 389, 251–260 (1997). Article  CAS  PubMed  ADS  Google Scholar  * McGinty, R. K., Henrici, R. C. & Tan, S. Crystal structure of the PRC1 ubiquitylation module bound

to the nucleosome. _Nature_ 514, 591–596 (2014). Article  CAS  PubMed  PubMed Central  ADS  Google Scholar  * Punjani, A. & Fleet, D. J. 3D variability analysis: resolving continuous

flexibility and discrete heterogeneity from single particle cryo-EM. _J. Struct. Biol_. 213, 107702 (2021). Article  CAS  PubMed  Google Scholar  * Nakane, T., Kimanius, D., Lindahl, E.

& Scheres, S. H. Characterisation of molecular motions in cryo-EM single-particle data by multi-body refinement in RELION. _eLife_ 7, e36861 (2018). Article  PubMed  PubMed Central 

Google Scholar  * Paull, T. T. et al. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. _Curr. Biol_. 10, 886–895 (2000). Article  CAS 

PubMed  Google Scholar  * Fox, D., III et al. Crystal structure of the BARD1 ankyrin repeat domain and its functional consequences. _J. Biol. Chem_. 283, 21179–21186 (2008). Article  CAS 

PubMed  PubMed Central  Google Scholar  * Li, M. & Yu, X. Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation. _Cancer Cell_ 23, 693–704 (2013). Article  CAS 

PubMed  PubMed Central  Google Scholar  * Billing, D. et al. The BRCT domains of the BRCA1 and BARD1 tumor suppressors differentially regulate homology-directed repair and stalled fork

protection. _Mol. Cell_ 72, 127–139.e8 (2018). Article  CAS  PubMed  PubMed Central  Google Scholar  * Eddins, M. J., Carlile, C. M., Gomez, K. M., Pickart, C. M. & Wolberger, C.

Mms2–Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation. _Nat. Struct. Mol. Biol_. 13, 915–920 (2006). Article  CAS  PubMed 

Google Scholar  * Sobhian, B. et al. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. _Science_ 316, 1198–1202 (2007). Article  CAS  PubMed  PubMed Central  ADS 

Google Scholar  * Wang, B. et al. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. _Science_ 316, 1194–1198 (2007). Article  CAS  PubMed  PubMed Central 

ADS  Google Scholar  * Kim, H., Chen, J. & Yu, X. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. _Science_ 316, 1202–1205 (2007). Article  CAS  ADS  PubMed

  Google Scholar  * Coleman, K. A. & Greenberg, R. A. The BRCA1–RAP80 complex regulates DNA repair mechanism utilization by restricting end resection. _J. Biol. Chem_. 286, 13669–13680

(2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Hu, Y. et al. RAP80-directed tuning of BRCA1 homologous recombination function at ionizing radiation-induced nuclear foci.

_Genes Dev_. 25, 685–700 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Xu, M. et al. Partitioning of histone H3–H4 tetramers during DNA replication-dependent chromatin

assembly. _Science_ 328, 94–98 (2010). Article  CAS  PubMed  ADS  Google Scholar  * Witus, S. R. et al. BRCA1/BARD1 site-specific ubiquitylation of nucleosomal H2A is directed by BARD1.

_Nat. Struct. Mol. Biol._ 28, 268–277 (2021). Article  CAS  PubMed  PubMed Central  Google Scholar  * Hu, Q., Botuyan, M. V., Cui, G., Zhao, D. & Mer, G. Mechanisms of ubiquitin

-nucleosome recognition and regulation of 53BP1 chromatin recruitment by RNF168/169 and RAD18. _Mol. Cell_ 66, 473–487.e9 (2017). Article  CAS  PubMed  PubMed Central  Google Scholar  *

Sundd, M., Iverson, N., Ibarra-Molero, B., Sanchez-Ruiz, J. M. & Robertson, A. D. Electrostatic interactions in ubiquitin: stabilization of carboxylates by lysine amino groups.

_Biochemistry_ 41, 7586–7596 (2002). Article  CAS  PubMed  Google Scholar  * Cui, G. et al. Structural basis of ubiquitin recognition by translesion synthesis DNA polymerase ι.

_Biochemistry_ 49, 10198–10207 (2010). Article  CAS  PubMed  Google Scholar  * Berndsen, C. E. & Wolberger, C. A spectrophotometric assay for conjugation of ubiquitin and ubiquitin-like

proteins. _Anal. Biochem_. 418, 102–110 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Bentley, M. L. et al. Recognition of UbcH5c and the nucleosome by the Bmi1/Ring1b

ubiquitin ligase complex. _EMBO J_. 30, 3285–3297 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Benirschke, R. C. et al. Molecular basis for the association of human E4B U

box ubiquitin ligase with E2-conjugating enzymes UbcH5c and Ubc4. _Structure_ 18, 955–965 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Su, D. et al. Structure and histone

binding properties of the Vps75–Rtt109 chaperone–lysine acetyltransferase complex. _J. Biol. Chem_. 286, 15625–15629 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Su, D. et

al. Structural basis for recognition of H3K56-acetylated histone H3–H4 by the chaperone Rtt106. _Nature_ 483, 104–107 (2012). Article  CAS  PubMed  PubMed Central  ADS  Google Scholar  *

Luger, K., Rechsteiner, T. J. & Richmond, T. J. Preparation of nucleosome core particle from recombinant histones. _Methods Enzymol_. 304, 3–19 (1999). Article  CAS  PubMed  Google

Scholar  * Makde, R. D., England, J. R., Yennawar, H. P. & Tan, S. Structure of RCC1 chromatin factor bound to the nucleosome core particle. _Nature_ 467, 562–566 (2010). Article  CAS 

PubMed  PubMed Central  ADS  Google Scholar  * Matsumoto, S. et al. DNA damage detection in nucleosomes involves DNA register shifting. _Nature_ 571, 79–84 (2019). Article  CAS  PubMed 

PubMed Central  Google Scholar  * Marks, B. D. et al. Multiparameter analysis of a screen for progesterone receptor ligands: comparing fluorescence lifetime and fluorescence polarization

measurements. _Assay Drug Dev. Technol_. 3, 613–622 (2005). Article  CAS  PubMed  Google Scholar  * Shukla, A. K. et al. Visualization of arrestin recruitment by a G-protein-coupled

receptor. _Nature_ 512, 218–222 (2014). Article  CAS  PubMed  PubMed Central  ADS  Google Scholar  * Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms

for rapid unsupervised cryo-EM structure determination. _Nat. Methods_ 14, 290–296 (2017). Article  CAS  PubMed  Google Scholar  * Scheres, S. H. RELION: implementation of a Bayesian

approach to cryo-EM structure determination. _J. Struct. Biol_. 180, 519–530 (2012). Article  CAS  PubMed  PubMed Central  Google Scholar  * Zivanov, J. et al. New tools for automated

high-resolution cryo-EM structure determination in RELION-3. _eLife_ 7, e42166 (2018). Article  PubMed  PubMed Central  Google Scholar  * Zheng, S. Q. et al. MotionCor2: anisotropic

correction of beam-induced motion for improved cryo-electron microscopy. _Nat. Methods_ 14, 331–332 (2017). Article  CAS  PubMed  PubMed Central  Google Scholar  * Tan, Y. Z. et al.

Addressing preferred specimen orientation in single-particle cryo-EM through tilting. _Nat. Methods_ 14, 793–796 (2017). Article  CAS  PubMed  PubMed Central  Google Scholar  * Liebschner,

D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. _Acta Crystallogr. D_ 75, 861–877 (2019). Article  CAS  Google Scholar 

* Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. _Acta Crystallogr. D_ 60, 2126–2132 (2004). Article  PubMed  CAS  Google Scholar  * Birrane, G., Varma, A.

K., Soni, A. & Ladias, J. A. Crystal structure of the BARD1 BRCT domains. _Biochemistry_ 46, 7706–7712 (2007). Article  CAS  PubMed  Google Scholar  * Edwards, R. A. et al. The BARD1

C-terminal domain structure and interactions with polyadenylation factor CstF-50. _Biochemistry_ 47, 11446–11456 (2008). Article  CAS  PubMed  Google Scholar  * Vijay-Kumar, S., Bugg, C. E.

& Cook, W. J. Structure of ubiquitin refined at 1.8 A resolution. _J. Mol. Biol_. 194, 531–544 (1987). Article  CAS  PubMed  Google Scholar  * Chen, V. B. et al. MolProbity: all-atom

structure validation for macromolecular crystallography. _Acta Crystallogr. D_ 66, 12–21 (2010). Article  CAS  PubMed  Google Scholar  * Pettersen, E. F. et al. UCSF Chimera—a visualization

system for exploratory research and analysis. _J. Comput. Chem_. 25, 1605–1612 (2004). Article  CAS  PubMed  Google Scholar  * Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges

in visualization and analysis. _Protein Sci_. 27, 14–25 (2018). Article  CAS  PubMed  Google Scholar  * Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on

UNIX pipes. _J. Biomol. NMR_ 6, 277–293 (1995). Article  CAS  PubMed  Google Scholar  * Lee, W., Tonelli, M. & Markley, J. L. NMRFAM-SPARKY: enhanced software for biomolecular NMR

spectroscopy. _Bioinformatics_ 31, 1325–1327 (2015). Article  PubMed  Google Scholar  * Schanda, P., Kupce, E. & Brutscher, B. SOFAST-HMQC experiments for recording two-dimensional

heteronuclear correlation spectra of proteins within a few seconds. _J. Biomol. NMR_ 33, 199–211 (2005). Article  CAS  PubMed  Google Scholar  * Berendsen, H. J. C., van der Spoel, D. &

van Drunen, R. GROMACS: a message-passing parallel molecular dynamics implementation. _Comput. Phys. Commun_. 91, 43–56 (1995). Article  CAS  ADS  Google Scholar  * Mukherjee, R. et al.

Calmodulin regulates MGRN1–GP78 interaction mediated ubiquitin proteasomal degradation system. _FASEB J_. 33, 1927–1945 (2019). Article  CAS  PubMed  Google Scholar  * Landrum, M. J. et al.

ClinVar: improving access to variant interpretations and supporting evidence. _Nucleic Acids Res_. 46, D1062–D1067 (2018). Article  CAS  PubMed  Google Scholar  Download references

ACKNOWLEDGEMENTS We are indebted to H. Scott, J. Myers and N. Meyer at the Pacific Northwest Cryo-EM Center (PNCC) for cryo-EM screenings and data collections, and to H. Scott for his

invaluable advice throughout this project; we are grateful to A. Sundborger-Lunna, P.-L. Chiu and A. Alam for providing instrument access and for collaboration on other cryo-EM projects; and

thank M. Schellenberg for generous instrument access and B. Bragantini for sharing unpublished findings. This research was supported by the US National Institutes of Health (NIH) grants R01

CA132878, R01 GM116829 and R35 GM136262 to G.M.; the Ovarian Cancer Research Alliance Liz Tilberis Award to M.V.B.; an Edward C. Kendall Fellowship in Biochemistry to Q.H.; and a Mayo

Clinic Cancer Center and Center for Biomedical Discovery Eagles Fellowship to D.Z. Cryo-EM screenings and data collections were supported by the NIH grant U24GM129547 and performed at the

PNCC at Oregon Health & Science University (OHSU) and accessed through the EMSL (grid.436923.9), a DOE Office of Science User Facility sponsored by the Office of Biological and

Environmental Research. AUTHOR INFORMATION Author notes * These authors contributed equally: Qi Hu, Maria Victoria Botuyan, Debiao Zhao AUTHORS AND AFFILIATIONS * Department of Biochemistry

and Molecular Biology, Mayo Clinic, Rochester, MN, USA Qi Hu, Maria Victoria Botuyan, Debiao Zhao, Gaofeng Cui, Elie Mer & Georges Mer * Department of Cancer Biology, Mayo Clinic,

Rochester, MN, USA Georges Mer Authors * Qi Hu View author publications You can also search for this author inPubMed Google Scholar * Maria Victoria Botuyan View author publications You can

also search for this author inPubMed Google Scholar * Debiao Zhao View author publications You can also search for this author inPubMed Google Scholar * Gaofeng Cui View author publications

You can also search for this author inPubMed Google Scholar * Elie Mer View author publications You can also search for this author inPubMed Google Scholar * Georges Mer View author

publications You can also search for this author inPubMed Google Scholar CONTRIBUTIONS G.M. conceived and supervised this work. G.M., Q.H., M.V.B. and D.Z. designed the experiments. Q.H.

determined the cryo-EM structures. G.C. and Q.H. performed the NMR spectroscopy experiments. M.V.B. cloned the different constructs. M.V.B., D.Z., Q.H. and E.M. produced and purified all

samples. M.V.B., Q.H., D.Z. and E.M. performed the functional assays. G.M. wrote the manuscript with major contributions from M.V.B. and Q.H., and input from all authors. CORRESPONDING

AUTHOR Correspondence to Georges Mer. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests. ADDITIONAL INFORMATION PEER REVIEW INFORMATION _Nature_ thanks

Daniel Durocher and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available. PUBLISHER’S NOTE Springer Nature remains

neutral with regard to jurisdictional claims in published maps and institutional affiliations. EXTENDED DATA FIGURES AND TABLES EXTENDED DATA FIG. 1 SITE-SPECIFIC UBIQUITYLATION OF

NUCLEOSOMAL HISTONES H2A AND H2AX BY BRCA1R-BARD1R AND UBCH5C. A, Left: time-course ubiquitylation of nucleosomal H2A catalysed by BRCA1R-BARD1R-UbcH5c probed using NMR spectroscopy at 25 

°C. Changes in signal intensities in the 1H -15N heteronuclear single quantum coherence (HSQC) spectra of the NCP harbouring 15N-labelled H2A-H2B were monitored. Right: overlay of the 1H

-15N HSQC spectra before and 1,000 min after the start of the ubiquitylation reaction. Signals from remnant tag residues are labelled in black. B, Left: Coomassie-stained gels as readout of

the ubiquitylation of wild-type (WT) NCP and NCPs harbouring double-point and triple-point mutations in H2A as indicated, using BRCA1R-BARD1R and UbcH5c. The lysine residues being

monoubiquitylated are indicated in red. Right: quantification of the NCP ubiquitylation from _n_ = 3 independent experiments. Bar graphs show the mean and s.d. for each data point. _P_

values were calculated using a two-sample, two-tailed Student _t_-test; *_P_ < 0.05, **_P_ < 0.01, ***_P_ < 0.001, NS means not significant. Exact _P_ values are provided in

Supplementary Table 1. For gel source data, see Supplementary Fig. 3. C, Estimation by simulation of the conformational space sampled by fluctuating conformations of H2A, H2AX and UbcH5c in

BRCA1R-BARD1R-UbcH5c-bound NCP (see Methods). The graph shows the ubiquitylation space accessible to the C-terminal tails of H2A (residues 118–129) and H2AX (residues 118–142). The red

dashed line indicates a 3–5 Å distance between the thiol group of the active site cysteine C85 of UbcH5c and an acceptor lysine ε-amino group that allows ubiquitin transfer. The cyan shaded

area below this line shows the histone residues accessible for ubiquitylation. A negative distance indicates that the distance between the sulfur atom of C85 and an α-carbon of H2A or H2AX

can be short enough to permit ubiquitylation if the corresponding acceptor residue is a lysine. Only H2A and H2AX residues 123–129 and 123–142, respectively, satisfy this condition. Three of

these residues are lysines in H2A (K125, K127 and K129) and H2AX (K127, K133 and K134). The conformational variability of UbcH5c was accounted for in these calculations. D, Left: amino acid

sequence alignment of H2A and H2AX C-terminal tails and time-course ubiquitylation of nucleosomal H2AX catalysed by BRCA1R-BARD1R-UbcH5c probed using NMR spectroscopy at 25 °C. Changes in

signal intensities in the 1H -15N HSQC spectra of the NCP harbouring 15N-labelled H2AX-H2B were monitored. Right: overlay of the 1H -15N HSQC spectra before and 1,000 min after the start of

the ubiquitylation reaction. Signals from remnant tag residues are labelled in black. E, Left: Coomassie-stained gels as readout of the ubiquitylation of the NCPs harbouring WT and

double-point and triple-point mutations in H2AX as indicated, using BRCA1R-BARD1R and UbcH5c. The lysine residues being monoubiquitylated are indicated in red. Right: quantification of the

NCP ubiquitylation from _n_ = 3 independent experiments. Bar graphs show the mean and s.d. for each data point. _P_ values were calculated using a two-sample, two-tailed Student _t_-test;

*_P_ < 0.05, **_P_ < 0.01, ***_P_ < 0.001, NS means not significant. Exact _P_ values are provided in Supplementary Table 1. For gel source data, see Supplementary Fig. 3. EXTENDED

DATA FIG. 2 PROCESSING OF CRYO-EM DATA FOR THE BRCA1R-BARD1R-UBCH5C-NUCLEOSOME COMPLEX. A, Flow chart showing the stages of cryo-EM image processing. A total of 5,490 micrographs was

collected on a Titan Krios 300 kV microscope and subjected to beam-induced motion correction. Data processing was done using cryoSPARC (v2.14) and RELION 3.0. The reconstruction of

BRCA1R-BARD1R-UbcH5c-NCP with the highest resolution was selected for building an atomic model. Cryo-EM density reconstruction for the apo NCP (particles with no detectable density for

BRCA1R-BARD1R-UbcH5c) was also carried out and is schematized by blue arrows. After 3D models were built, the r.m.s.d. over all NCP backbone atoms between the apo and complex states is 0.29

Å, not including the histone tails, which are not detected in the two densities. B, Multibody refinement and conformational dynamics analysis of BRCA1R-BARD1R-UbcH5c-NCP using RELION 3.1.

Six principal components were used to describe motions among three rigid bodies corresponding to BRCA1R-BARD1R, UbcH5c and the NCP, with the two extreme conformations for each rigid body

displayed in grey and blue. Rigid body movements of BRCA1R-BARD1R, UbcH5c and BRCA1R-BARD1R-UbcH5c as a whole are indicated by orange, red and black curved arrows, respectively. EXTENDED

DATA FIG. 3 VALIDATION OF EM DATA AND SAMPLE CRYO-EM DENSITY FOR THE BRCA1R-BARD1R-UBCH5C-NUCLEOSOME COMPLEX. A, Local resolution distribution displayed on the reconstructed cryo-EM density

map of the BRCA1R-BARD1R-UbcH5c-nucleosome complex. B, Top: Euler angle distribution generated using RELION 3.0 for the particles used in the final reconstruction. Each bar has a height and

colour indicative of the number of particles (increasing from blue to red) in a defined orientation. Bottom: particle angular distribution heatmap generated using cryoSPARC (v2.14). C,

Gold-standard Fourier shell correlation (GSFSC) curves for the final refinement in cryoSPARC (v2.14). Non-uniform refinement led to a 3.28 Å resolution map. D, Quantification of directional

resolution anisotropy using a 3D Fourier shell correlation (3DFSC) algorithm in the 3DFSC server65. E, Fourier shell correlation (FSC) curves between model-calculated density and the final

cryo-EM density map generated using PHENIX. Resolution at FSC 0.5 is indicated. F, Representative regions of the cryo-EM density map for the nucleosome components (histones and DNA) of the

complex. G, Representative regions of the cryo-EM density map for the BRCA1R, BARD1R and UbcH5c interfaces. The four-helix bundle of BRCA1R-BARD1R is highlighted on the left. H,

Representative regions of the cryo-EM density map for the interfaces involving BRCA1R and BARD1R interactions with the nucleosome. The first and second representations from the left

highlight BRCA1R interaction with the nucleosome acidic patch and BARD1R interaction with H2B, respectively. EXTENDED DATA FIG. 4 EFFECTS OF STRUCTURE-BASED MUTATIONS IN BRCA1R, BARD1R AND

NUCLEOSOMAL HISTONE PROTEINS H2A AND H2B ON UBIQUITIN CONJUGATION TO H2A. A, Top: representative Coomassie-stained gel of time-course ubiquitylation assays of the NCP using UbcH5c and

BRCA1R-BARD1R, wild type (WT) and with indicated mutations in BRCA1R. Bottom: quantification of the NCP ubiquitylation from _n_ = 3 independent experiments. Bar graphs show the mean and s.d.

for each data point. _P_ values were calculated using a two-sample, two-tailed Student _t_-test; *_P_ < 0.05, **_P_ < 0.01, ***_P_ < 0.001, NS means not significant. Exact _P_

values are provided in Supplementary Table 1. For gel source data, see Supplementary Fig. 4. B, Left: representative Coomassie-stained gels of time-course ubiquitylation assays of WT and

indicated H2A mutant NCPs by WT BRCA1R-BARD1R and UbcH5c. Right: quantification of the NCP ubiquitylation from _n_ = 3 independent experiments. Bar graphs show the mean and s.d. for each

data point. _P_ values were calculated using a two-sample, two-tailed Student _t_-test; *_P_ < 0.05, **_P_ < 0.01, ***_P_ < 0.001, NS means not significant. Exact _P_ values are

provided in Supplementary Table 1. For gel source data, see Supplementary Fig. 4. C, Similar to B but using WT and indicated H2B mutations in the NCP. Exact _P_ values are provided in

Supplementary Table 1. For gel source data, see Supplementary Fig. 4. D, Top: representative Coomassie-stained gel of time-course ubiquitylation assays of the NCP using UbcH5c and

BRCA1R-BARD1R, with the indicated mutations in BARD1R. The ubiquitylation assay carried out with WT BRCA1R-BARD1R is shown in A. Bottom: quantification of the NCP ubiquitylation from _n_ = 3

independent experiments. Bar graphs show the mean and s.d. for each data point. _P_ values were calculated using a two-sample, two-tailed Student _t_-test; *_P_ < 0.05, **_P_ < 0.01,

***_P_ < 0.001, NS means not significant. Exact _P_ values are provided in Supplementary Table 1. For gel source data, see Supplementary Fig. 4. E, Overlays of 1H-15N HSQC NMR spectra of

WT BRCA1R-BARD1R versus BRCA1R-BARD1R harbouring the BARD1R P89A or W91A mutation. BRCA1R and BARD1R signals for which there was a change in chemical shift are labelled with BC and BD

prefixes, respectively. The spectra demonstrate that the mutant proteins are well folded. The changes in chemical shifts for the W91A mutant map to residues close in space to the mutation

site and can be attributed to altered ring current effect. These affected residues are coloured red and cyan on the NMR structure of BRCA1R-BARD1R. The multiple side-chain conformations of

W91 in the NMR ensemble are displayed. EXTENDED DATA FIG. 5 STRUCTURAL AND FUNCTIONAL COMPARISON OF BRCA1R-BARD1R-UBCH5C AND RING1BR-BMI1R-UBCH5C IN ASSOCIATION WITH THE NUCLEOSOME AND

DYNAMICS OF THE BRCA1R-UBCH5C INTERACTION. A, Top: fluorescence polarization nucleosome-binding curves showing that BRCA1R-BARD1R and BRCA1R-BARD1R-UbcH5c bind to the NCP with similar

affinities, lower than the affinity of RING1BR-BMI1R for the NCP. Data are mean and s.d. for each data point (_n_ = 3 independent experiments). _K_d values are indicated. Bottom: control

binding curves for the RING1BR-BMI1R-NCP interaction at two salt concentrations. While our experiments were done with 50 mM NaCl, previously published experiments probing the

RING1BR-BMI1R-NCP interaction were done with 100 mM NaCl. The higher RING1BR-BMI1R-NCP _K_d that we obtained at 100 mM NaCl is similar to published data34. B, Surface representations of the

3D structures of BRCA1R-BARD1R-UbcH5c-NCP and RING1BR-BMI1R-UbcH5c-NCP shown side-by-side with identical orientations of the NCP to highlight the radically different positioning of UbcH5c

relative to the NCP in the two complexes. C, Left: representative Coomassie-stained gels of ubiquitylation assays of the NCP by UbcH5c and BRCA1R-BARD1R or RING1BR-BMI1R using wild-type (WT)

proteins and the indicated UbcH5c and BRCA1R mutants. Right: quantification of the NCP ubiquitylation from _n_ = 3 independent experiments. Bar graphs show the mean and s.d. for each data

point. _P_ values were calculated using a two-sample, two-tailed Student _t_-test; *_P_ < 0.05, **_P_ < 0.01, ***_P_ < 0.001, NS means not significant. Exact _P_ values are provided

in Supplementary Table 1. For gel source data, see Supplementary Fig. 5. D, Top: overlay of the 1H-15N NMR HSQC spectra of BRCA1R-BARD1R-UbcH5c (red), BRCA1R-BARD1R (cyan) and UbcH5c (gold)

highlighting 12 residues (black labels) near the BRCA1R-UbcH5c interface for which NMR signals disappear or become very weak due to exchange broadening upon formation of the

BRCA1R-BARD1R-UbcH5c complex, consistent with motions on the microsecond-to-millisecond timescale. The signals of seven other UbcH5c residues (blue labels), distant from the interface with

BRCA1R, are also exchange broadened because of allosteric effects as previously noted for other UbcH5c and related complexes53,78. Bottom: surface representation of the BRCA1R-BARD1R-UbcH5c

complex. The regions for which NMR signals disappear due to exchange broadening upon formation of the BRCA1R-BARD1R-UbcH5c complex are highlighted in yellow. The active site C85 of UbcH5c is

shown in red. EXTENDED DATA FIG. 6 FLOW CHART SHOWING THE STAGES OF CRYO-EM IMAGE PROCESSING FOR BARD1 (ARD-BRCT) IN COMPLEX WITH THE NUCLEOSOME UBIQUITYLATED AT H2A K13 AND K15. A total of

5,051 micrographs was collected on a Titan Krios 300 kV microscope and subjected to beam-induced motion correction. Data processing was done using cryoSPARC (v2.15). The reconstruction with

the highest resolution was selected for building an atomic model. EXTENDED DATA FIG. 7 VALIDATION OF EM DATA FOR BARD1 (ARD-BRCT) IN COMPLEX WITH THE NUCLEOSOME UBIQUITYLATED AT H2A K13 AND

K15. A, Local resolution distribution displayed on the reconstructed cryo-EM density map of BARD1 (ARD-BRCT) bound to the H2AK13ubK15ub-containing NCP. B, Top: Euler angle distribution

generated using RELION 3.0 for the particles used in the final reconstruction. Each bar has a height and colour indicative of the number of particles (increasing from blue to red) in a

defined orientation. Bottom: particle angular distribution heatmap generated using cryoSPARC (v2.15). C, Gold-standard Fourier shell correlation (GSFSC) curves for the final refinement in

cryoSPARC (v2.14). Non-uniform refinement led to a 2.94 Å resolution map. D, Quantification of directional resolution anisotropy using a 3D Fourier shell correlation (3DFSC) algorithm in the

3DFSC server65. E, Fourier shell correlation (FSC) curves between model-calculated density and the final cryo-EM density map generated using PHENIX. Resolution at FSC 0.5 is indicated.

EXTENDED DATA FIG. 8 SAMPLE CRYO-EM DENSITY OF THE BARD1 (ARD-BRCT)-UBIQUITYLATED NUCLEOSOME COMPLEX. A, Representative regions of the cryo-EM density map for the different components

(histones, DNA, BARD1-ARD, BARD1-BRCT and ubiquitin) of the complex. B, Representative regions of the cryo-EM density map highlighting global interfaces. C, Representative regions of the

cryo-EM density map highlighting details of the various interfaces in the complex. EXTENDED DATA FIG. 9 UBIQUITYLATED NUCLEOSOME-BINDING PROPERTIES OF BARD1 (ARD-BRCT) AND ASSOCIATED

INHIBITION OF K63-MEDIATED POLYUBIQUITIN CHAIN FORMATION. A, Top: fluorescence polarization binding curves for BARD1 (ARD-BRCT), wild type (WT) and with the indicated mutations in the ARD

domain, added to fluorescently labelled H2AK13ubK15ub-bearing NCP. GST was used as a control since BARD1 (ARD-BRCT) was GST-tagged. Data are mean and s.d. for each data point (_n_ = 3

independent experiments). _K_d values are indicated. ND, not determined. Bottom: similar to the top panel but with the indicated mutations in the tandem BRCT domain. B, Left: cryo-EM density

near the ubiquitin isopeptide bond linkage in the structure of BARD1 (ARD-BRCT) in complex with H2AK13ubK15ub-bearing NCP. Only one ubiquitin molecule, interacting with BARD1 and NCP

surfaces (that is, bound ubiquitin), is detected in the density. The weak and blurry density for the isopeptide bond region is compatible with the bound ubiquitin being linked to H2A K13 or

H2A K15, suggesting binding exchange between H2AK13ub and H2AK15ub. Lack of density for a second ubiquitin molecule is probably due to flexibility in the unbound state. Right: ubiquitylation

reaction of BARD1 (ARD-BRCT)-H2A-H2B fusion (labelled as Fusion) by RNF168, UbcH5c and UBA1 showing that there are two ubiquitin molecules attached to H2A (at K13 and K15) in the purified

samples used for cryo-EM. Data shown are representative of _n_ = 5 independent experiments. For gel source data, see Supplementary Fig. 6. C, Cryo-EM density at BARD1 BRCT-ubiquitin (left)

and H2B-ubiquitin (right) interfaces in the structure of BARD1 (ARD-BRCT) bound to the NCP ubiquitylated at H2A K13 and K15. Ubiquitin K63 and E64 contact BARD1 while ubiquitin I44, G47, H68

and V70 contact H2B. D, Location of the putative phosphate-binding site in the BARD1 tandem BRCT domain. The predicted phosphate-binding residues S575, G576, L618 and K619 are highlighted

in red. E, Left: MMS2-Ubc13-catalysed polyubiquitin chain elongation at H2AK13ubK15ub in the NCP was inhibited by adding increasing amounts of GST-tagged BARD1 (ARD-BRCT), up to 16 times

molar excess. Ubiquitylation efficiency was calculated as a ratio of the total intensities of the ubiquitylated products in that particular western blot (WB) lane against the lane with

uninhibited MMS2-Ubc13 activity. Data are mean and s.d. for each data point from _n_ = 3 independent experiments. _P_ values were calculated using a two-sample, two-tailed Student _t_-test;

*_P_ < 0.05, **_P_ < 0.01, ***_P_ < 0.001, NS means not significant. Exact _P_ values are provided in Supplementary Table 1. Right: representative WB images depicting inhibition of

the MMS2-Ubc13-catalysed polyubiquitin chain elongation at H2AK13ubK15ub in the NCP by GST-tagged BARD1 (ARD-BRCT) but not by GST. The non-ubiquitylated NCP, used as a control substrate,

shows chain elongation of free ubiquitin only by MMS2-Ubc13, uninhibited by BARD1 (ARD-BRCT). All lanes with ATP show formation of di-ubiquitin with additional chain extension by MMS2-Ubc13,

demonstrating that BARD1 or GST do not inhibit MMS2-Ubc13. For gel source data, see Supplementary Fig. 6. EXTENDED DATA FIG. 10 BARD1 MISSENSE VARIANTS THAT MAP NEAR THE INTERDOMAIN AND

INTERMOLECULAR INTERFACES IN THE 3D STRUCTURE OF BARD1 (ARD-BRCT) IN COMPLEX WITH THE UBIQUITYLATED NUCLEOSOME. The side chains of BARD1 (ARD-BRCT) residues for which missense variants were

identified in patients with cancer are highlighted on the 3D structure of BARD1 (ARD-BRCT)-ubiquitylated NCP. Only variants that are located near the interdomain and intermolecular

interfaces are shown with a different colour for each interface. The amino acids are labelled when they are directly involved in interdomain or intermolecular interactions in the BARD1

(ARD-BRCT)-ubiquitylated NCP structure. The variants were obtained from the ClinVar database maintained at the US National Institutes of Health79. SUPPLEMENTARY INFORMATION SUPPLEMENTARY

INFORMATION This file contains Supplementary Text, Supplementary Figures 1-7 and Supplementary Tables 1-2. REPORTING SUMMARY PEER REVIEW FILE VIDEO 1 Three-dimensional variability analysis

of the BRCA1-BARD1-UbcH5c-nucleosome complex. VIDEO 2 Multi-body analysis of the BRCA1-BARD1-UbcH5c-nucleosome complex. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE

CITE THIS ARTICLE Hu, Q., Botuyan, M.V., Zhao, D. _et al._ Mechanisms of BRCA1–BARD1 nucleosome recognition and ubiquitylation. _Nature_ 596, 438–443 (2021).

https://doi.org/10.1038/s41586-021-03716-8 Download citation * Received: 17 September 2020 * Accepted: 10 June 2021 * Published: 28 July 2021 * Issue Date: 19 August 2021 * DOI:

https://doi.org/10.1038/s41586-021-03716-8 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not

currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative